Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BenRex: Benralizumab in severe eosinophilic asthma
NCT04102800Phase 4Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Sep 2019
- Primary completion
- Feb 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of benralizumab in eosinophilic asthma (EA), sponsored by NHS Greater Glasgow and Clyde. Started Sep 2019; status: completed.
02
Drugs
benralizumab
03
Conditions
eosinophilic asthma (EA)
Beyond the preview
Go deeper on NCT04102800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04102800.